Intérêt et faisabilité d’un programme de réhabilitation personnalisé pour les patients en post-allogreffe de moelle osseuse
S. Jacquin-Courtois(Centre de Recherche Astrophysique de Lyon), Mauricette Michallet(Institut d’Hématologie et d’Oncologie Pédiatrique), Xavier Thomas(Hôpital Lyon Sud), Sophie Ducastelle-Leprêtre(Hospices Civils de Lyon), Franck E. Nicolini(Hôpital Lyon Sud), Fiorenza Barraco(Hôpital Lyon Sud), M. Jacquet(Centre de Recherche Astrophysique de Lyon), C. Devismes(Centre de Recherche Astrophysique de Lyon)
Cited by 2
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547